Thursday, Aug 06, 2020 | Last Update : 07:45 AM IST

135th Day Of Lockdown

Maharashtra46826530552116476 Tamil Nadu2734602148154461 Andhra Pradesh1864611043541681 Karnataka151449746792804 Delhi1402321261164044 Uttar Pradesh104388605581857 West Bengal83800589621846 Telangana7095850814576 Gujarat65704485612529 Bihar6203140760349 Assam4816233429115 Rajasthan4667932832732 Haryana3779631226448 Odisha3768124483258 Madhya Pradesh3508225414912 Kerala279561629988 Jammu and Kashmir2239614856417 Punjab1901512491462 Jharkhand140705199129 Chhatisgarh10109761369 Uttarakhand8008484795 Goa7075511460 Tripura5520367528 Puducherry4147253758 Manipur301818147 Himachal Pradesh2879171013 Nagaland24056594 Arunachal Pradesh179011053 Chandigarh120671520 Meghalaya9173305 Sikkim7832971 Mizoram5022820
  Technology   Mobiles & Tabs  16 Jun 2020  How about letting your child play a videogame to help with ADHD?

How about letting your child play a videogame to help with ADHD?

AFP
Published : Jun 16, 2020, 9:20 pm IST
Updated : Jun 16, 2020, 9:20 pm IST

A videogame called EndeavorRx has been approved by the USFDA for children aged 8-12 who have been diagnosed with ADHD.

The USFDA said EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD and is the first game-based therapeutic approved for any type of condition. (Photo | Screengrab)
 The USFDA said EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD and is the first game-based therapeutic approved for any type of condition. (Photo | Screengrab)

Washington: US health officials have approved the first game-based treatment for children with attention deficit hyperactivity disorder, part of a trend toward “digital therapeutics” or software to address certain conditions.

The Food and Drug Administration said Monday it approved the sale by prescription of the game EndeavorRX from health tech startup Akili Interactive for children aged 8-12 who have been diagnosed with ADHD.

 

The FDA said this was the first digital therapeutic intended to treat ADHD, as well as the first game-based therapeutic approved for any type of condition.

The game, designed to improve cognitive function, is designed as part of a programme that may also include other kinds of therapy, medication, and educational programs.

“The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics,” said Jeffrey Shuren, director of the FDA Center for Devices and Radiological Health.

Digital therapeutics have been approved for certain treatments such as addiction disorders and are being testing for a range of other conditions from chronic pain to anxiety.

 

EndeavorRX allows children to control cartoon-like characters on a type of hoverboard and is designed to target and activate neural systems through sensory stimuli and motor challenges to improve cognitive functioning.

“We’re proud to make history today with FDA’s decision,” said Eddie Martucci, chief executive officer of Akili.

“With EndeavorRx, we’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment.”

The approval of EndeavorRx followed studies of some 600 children diagnosed with ADHD.

The company said the research found that after four weeks of EndeavorRx treatment, one-third of children no longer had a measurable attention deficit on at least one measure of objective attention and that about half of parents saw a meaningful change in their child’s day-to-day impairments after one month of treatment with EndeavorRx.

 

Tags: videogames, adhd, usfda